Leadership Pathway Program Awardees
The Leadership Pathway Program (LPP) enhances the career advancement of a diverse group of leaders through activities that increase their knowledge of ASTRO’s governance structure, expand their networks through their assignments to an ASTRO Council and augment their leadership skills. Congratulations to the 2024-2026 Leadership Pathway Program Awardees.
Current Awardees
 Christopher Brett, MD, MBA, DABR2024-2026 LPP AwardeeInstitution: University of Tennessee Medical Center Christopher Brett, MD, MBA, DABR, is an Assistant Professor with the University of Tennessee Medical Center, where he has a clinical focus on the treatment of head and neck cancer, and a research emphasis on improving outcomes and access for care for the patients of Appalachia he serves. Dr. Brett earned his medical degree from the University of Missouri-Kansas City School of Medicine, graduating summa cum laude, and completed residency training in internal medicine at the Mayo Clinic Florida prior to completing a second residency in radiation oncology at Vanderbilt University Medical Center, where he served as Chief Resident. In efforts to improve his effectiveness in leading change beyond his personal clinical practice, he recently completed the Physician Executive MBA program at the University of Tennessee’s Haslam College of Business. Dr. Brett is excited to investigate applications of technology to lessen the impacts of health disparities in cancer care. Current projects include a collaboration leveraging artificial intelligence to identify and provide targeted support to patients at risk of radiation therapy interruption, as well novel programs to improve the physical health and activity of rural cancer survivors. His research also examines the impact of social determinants of health on cancer treatment outcomes. Active within his professional organizations, Dr. Brett currently serves on ASTRO’s Congressional Relations Subcommittee and has previously been a member of ASCO, ARRO and AMA-RFS sub committees with focuses including quality, patient safety and global health. |
 Avinash Chaurasia, MD2024-2026 LPP AwardeeInstitution: Brooks Army Medical Center Avinash Chaurasia, MD, embarked on his educational and military career at West Point, where he graduated with his Bachelor’s Degree and commissioned as a U.S. Army officer. He attended medical school at UC Irvine School of Medicine and graduated with distinction in humanities and arts. He completed his radiation oncology residency at the National Capital Consortium (Walter Reed National Military Medical Center and NIH), during which he led efforts to revamp the residency curriculum and was awarded the Outstanding Resident Teaching Award. He serves as the Medical Director, Research Lead, Brachytherapy Lead and GME Lead within the Radiation Oncology Service at BAMC. He is passionate about leadership, mentorship, resident/trainee teaching and health equity. He previously served as the Mentorship lead for the ARRO Equity and Inclusion Subcommittee, helping lead the establishment of the first minority and health equity-focused mentorship program for Radiation Oncology. He is passionate about grassroots-level efforts to advance progress throughout the spectrum of education and clinical care and is a member of the ASTRO Climate Change Task Force and Community Practice Task Force. |
 Heng Li, PhD2024-2026 LPP AwardeeInstitution: Johns Hopkins University Heng Li, PhD, is an Associate Professor, Chief Proton Physicist and Vice Chief of the Division of Medical Physics in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University. He is also an Adjunct Associate Professor in the Department of Physics and Astronomy at Howard University. He completed his PhD degree in Electrical and Computer Engineering at the University of Virginia in 2006 and subsequently received his Postdoctoral Fellowship and Therapeutic Medical Physics Residency training at the University of Texas MD Anderson Cancer Center. Dr. Li's research area includes image guidance for radiotherapy, particle therapy, implementation of clinical trials, cancer health equity and global health. He is certified by the American Board of Radiology (ABR) in therapeutic medical physics and is a fellow of the American Association of Physicists in Medicine (AAPM). |
 Andrew McDonald, MD2024-2026 LPP AwardeeInstitution: University of Alabama at Birmingham Andrew McDonald, MD, is a radiation oncologist at the University of Alabama at Birmingham where he holds the ROAR Southeast Cancer Foundation endowed chair. He is a member of UAB’s Institute for Cancer Outcomes and Survivorship with a research focus on strategies to improve quality of life for cancer survivors. He has served as the director of the UAB radiation oncology residency program since 2020. He is an active member of both ASTRO and ASCO where he has served on multiple panels. He clinically specializes in the treatment of genitourinary and gastrointestinal malignancies and is actively engaged with clinical trials for these areas. |
 Fabio Ynoe de Moraes, PhD, MBA2023-2025 LPP AwardeeInstitution: Kingston Health Sciences Center Fabio Ynoe de Moraes, PhD, MBA, is an Associate Professor, Radiation Oncologist, and holds a leadership role in innovation and Global oncology within the Department of Oncology, Division of Radiation Oncology, at Queen's University and Kingston Health Sciences Center in Kingston, Ontario, Canada. Dr. Moraes is also a principal investigator at the Queen's Cancer Research Institute in Kingston. Dr. Moraes has completed a PhD in Health Sciences, an advanced degree program in Artificial Intelligence, and an MBA. His research agenda focuses on exploring the intersection of global oncology, health policy and innovation. Dr. Moraes has published more than 160 manuscripts in indexed, high-impact journals, including The New England Journal of Medicine, The Lancet Oncology, JAMA Oncology, Nature Biotechnology, JNCI and others. |
 Joanna Yang, MD, MPH2024-2026 LPP AwardeeInstitution: Washington University of St. Louis Joanna C. Yang, MD, MPH, is an associate professor of radiation oncology specializing in the treatment of lymphomas and breast cancers. Through clinical care, research and policy work, her goals are to improve long-term outcomes for all of her patients by improving efficacy, minimizing toxicity, ensuring treatment value and affordability, and exploring the potential synergies of radiation therapy with novel drugs. Dr. Yang earned a medical degree from the Mount Sinai School of Medicine in New York City, where she graduated with Distinction in Research and Distinction in Medical Education. She then completed a transitional year internship and radiation oncology residency at Memorial Sloan Kettering Cancer Center. At MSKCC, Dr. Yang served as chief resident and completed a lymphoma fellowship. Dr. Yang has an MPH from the Harvard School of Public Health in the Clinical Effectiveness Track. She was selected as a Health Policy Fellow for the American Society of Clinical Oncology from 2017-2018 and remains active with ASCO. She is also an active council member of the International Lymphoma Radiation Oncology Group. |
